PFG Investments LLC lifted its stake in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 9.9% in the 4th quarter, ...

Corcept Therapeutics Incorporated (NASDAQ:CORT – Get Free Report) has earned an average recommendation of “Buy” from the five ratings firms that are covering the company, Marketbeat reports. Five ...

Alterity Therapeutics (ATHE) announced topline results from the ATH434-201 randomized, double-blind, placebo-controlled Phase 2 clinical trial in ...

In a report released today, Kelly Shi from Jefferies assigned a Buy rating to Summit Therapeutics (SMMT – Research Report), with a price target ...

Outlook Therapeutics (OTLK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Douglas ...

Neumora Therapeutics Inc.’s stock tumbled 81% Thursday after the clinical-stage biotech said a late-stage trial of a treatment for major depressive disorder failed to meet its main goals.

Shionogi & Co. has been awarded a $375 million project agreement by the Biomedical Advanced Research and Development Authority (BARDA) to develop S-892216, a long-acting injectabl ...

Want to improve your health and sleep this year? A smart ring could help. Smart rings track everything a smartwatch does -- sleep, activity, and wellness -- all around your finger and without a ...

There are flashy smart home tools headed to store shelves this year, but those might not be the products that make the biggest splash in 2025. David lives in Brooklyn where he's spent more than a ...

Citing preliminary financials, TG Therapeutics (NASDAQ:TGTX) announced Tuesday that the U.S. net sales from its multiple sclerosis therapy, Briumvi, for Q4 and full-year 2024 well exceeded its ...